Corvus Pharmaceuticals Earnings
NASDAQ: CRVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.52+0.31 (+3.04%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 10.52 0.00%
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.21
Corvus Pharmaceuticals earnings summary
Corvus Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-0.21.
Summary generated from market data by MetaCap's automated system. Methodology